Nephrogenic diabetes insipidus

Current Opinion in Nephrology and Hypertension

Volumn 9, Issue 6, 2000, Pages 591-595

  Deen, Peter M T ^a,b   Marr, Nannette ^a   Kamsteeg, Erik Jan ^a   Van Balkom, Bas W M ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b 162 Cell Physiology   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN; ARGIPRESSIN; ARGIPRESSIN RECEPTOR; DESMOPRESSIN; WATER;

FLUID BALANCE; GENE MUTATION; GENE THERAPY; GENE TRANSFER; HEREDITY; HUMAN; NEPHROGENIC DIABETES INSIPIDUS; NOTE; PATHOGENESIS; PRIORITY JOURNAL; SIDE EFFECT;

ANIMALS; AQUAPORIN 2; AQUAPORIN 6; AQUAPORINS; DIABETES INSIPIDUS, NEPHROGENIC; HUMANS; MUTATION; RECEPTORS, VASOPRESSIN;

EID: 0033677594     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200011000-00001     Document Type: Note

References (51)

1. Renal aquaporins: Key roles in water balance and water balance disorders
2. Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus
3. Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus
4. Requirement of human renal water channel AQP2 for vasopressin-dependent concentration of urine
5. A variant of nephrogenic diabetes insipidus: V2 receptor abnormality restricted to the kidney
6. Normal fibrinolytic responses to 1-desamino-8-D-arginine vasopressin in patients with nephrogenic diabetes insipidus caused by mutations in the aquaporin 2 gene
7. Fibrinolytic responses to 1-desamino-8-D-arginine-vasopressin in patients with congenital nephrogenic diabetes insipidus
8. Assignment of the human gene for the water channel of renal collecting duct aquaporin 2 (AQP2) to chromosome 12 region q12→q13
9. Cloning, characterization, and chromosomal mapping of human aquaporin of collecting duct
10. Generation and phenotype of a transgenic knockout mouse lacking the mercurial-insensitive water channel aquaporin-4
11. Nephrogenic diabetes insipidus in mice lacking aquaporin-3 water channels
12. Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel
13. Phenotypic and genetic characterization of a new nephrogenic diabetes insipidus (NDI) mouse model
14. Localization of the human gene for aquaporin 3 (AQP3) to chromosome 9, region p21→p12, using fluorescent in-situ hybridization
15. The human AQP4 gene: Definition of the locus encoding two water channel polypeptides in brain
16. Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption
17. Localization and functional characterization of rat kidney-specific chloride channel, CIC-K1
18. Folding of secretory and membrane proteins
19. Protein processing: A role in the pathophysiology of genetic disease
20. Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator
21. Vasopressin type-2 receptor and aquaporin-2 water channel mutants in nephrogenic diabetes insipidus
22. The LDL receptor locus in familial hypercholesterolemia: Mutational analysis of a membrane protein
23. NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor
24. Molecular and conformational features of a transport-relevant domain in the C-terminal tail of the vasopressin V(2) receptor
25. Nephrogenic diabetes insipidus: Functional analysis of new AVPR2 mutations identified in Italian families
26. V2 vasopressin receptor dysfunction in nephrogenic diabetes insipidus caused by different molecular mechanisms
27. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants
28. Biochemical basis of partial nephrogenic diabetes insipidus phenotypes
29. Molecular aspects of vasopressin receptor function
30. Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families
31. In vivo iodination of a misfolded proinsulin reveals co-localized signals for Bip binding and for degradation in the ER
32. The role of conserved extracellular cysteine residues in vasopressin V2 receptor function and properties of two naturally occurring mutant receptors with additional extracellular cysteine residues
33. Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: Molecular basis of a mild clinical phenotype
34. An extracellular congenital nephrogenic diabetes insipidus mutation
35. The effect of eight V2 vasopressin receptor mutations on stimulation
36. Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus
37. A low-affinity vasopressin V2-receptor gene in a kindred with X-linked nephrogenic diabetes insipidus
38. Functional characterization of five V2 vasopressin receptor gene mutations
39. Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: Analysis of expression, processing, and function
40. Nephrogenic diabetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase
41. Water channels encoded by mutant aquaporin-2 genes in nephrogenic diabetes insipidus are impaired in their cellular routing
42. New mutations in the AQP2 gene in nephrogenic diabetes insipidus resulting in functional but misrouted water channels
43. Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones
44. A novel mutation in the aquaporin-2 (AQP2) gene causing autosomal dominant nephrogenic diabetes insipidus [Abstract]
45. An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex
46. An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus
47. In vitro expression of mutations in the V2 receptor gene - Confirmation of their role in the pathogenesis of X-linked nephrogenic diabetes insipidus
48. Identification and characterization of aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus with partial vasopressin response
49. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a coexpressed receptor polypeptide
50. Gene therapy in the vasculature and the kidney
51. Novel pharmacologic therapies for cystic fibrosis